COSMOS HEALTH INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $65.3M | $54.4M | $53.4M | $50.3M | $56.2M | $55.4M | $39.7M |
| Cost of Revenue | — | $57.4M | $50.1M | $49.0M | $44.4M | $47.9M | $47.3M | $36.0M |
| Gross Profit | — | $7.9M | $4.3M | $4.3M | $6.0M | $8.3M | $8.1M | $3.7M |
| Gross Margin | — | 12.1% | 7.9% | 8.1% | 11.8% | 14.8% | 14.5% | 9.2% |
| Operating Expenses | ||||||||
| Research & Development | — | $519.4K | $533.3K | $164.9K | — | — | — | — |
| SG&A Expense | — | $15.6M | $11.7M | $19.6M | $10.2M | $9.2M | $2.1M | $3.3M |
| Operating Income | — | $-16.7M | $-15.5M | $-21.8M | $-7.5M | $-4.5M | $2.7M | $-255.8K |
| Operating Margin | — | -25.6% | -28.6% | -40.9% | -14.8% | -8.1% | 4.9% | -0.6% |
| Interest Expense | — | $1.9M | $1.0M | $866.5K | $2.3M | $2.8M | $2.8M | $-1.4M |
| Pretax Income | — | $-19.1M | $-16.2M | $-18.5M | $-13.1M | $-7.8M | $1.2M | $-3.1M |
| Income Tax Expense | — | $0 | $0 | $0 | $-775.1K | $114.0K | $-377.5K | $182.8K |
| Net Income | — | $-19.1M | $-16.2M | $-18.5M | $-13.8M | $-8.0M | $820.8K | $-3.3M |
| Net Margin | — | -29.3% | -29.7% | -34.7% | -27.5% | -14.2% | 1.5% | -8.3% |
| EPS (Basic) | — | $-0.63 | $-1.17 | $-2.15 | $-5.53 | $-1.32 | $0.00 | $-0.01 |
| EPS (Diluted) | — | $-0.63 | $-1.17 | $-2.15 | $-5.53 | $-1.32 | $0.00 | $-0.01 |
| Shares Outstanding (Basic) | 50.8M | 30.3M | 19.1M | 12.0M | 11.6M | 11.8M | 238.9M | 238.9M |
| Shares Outstanding (Diluted) | 50.8M | 30.3M | 19.1M | 12.0M | 11.6M | 11.8M | 239.5M | 238.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |